Companies Seagen

Seagen (SGEN): executive pay, fiscal 2022

Free brief. Every figure links to the company’s own filing.

Seagen no longer files a proxy statement; its last pay data is FY2022.

All products and prices

CEO total pay$57,460,546CEO David Epstein · source

Say-on-pay support54.38%Latest vote · source

CEO vs. named peers99th pct.Of 14 peer CEOs

CEO pay, last three years

$57,460,546FY2022

CEO total pay was $57,460,546 in fiscal 2022; the brief holds no earlier figure for this CEO.

FY2022: salary $190,385 · bonus $0 · stock awards $14,815,386 · option awards $42,381,246

Frequently asked questions

Who was the highest-paid executive at Seagen in fiscal 2022?

As disclosed, David Epstein (Chief Executive Officer) was the highest-paid executive at Seagen in fiscal 2022, with total compensation of $57,460,546.

How does Seagen's chief executive pay compare to its disclosed peer group?

As disclosed, David Epstein's total compensation ranked at the 99th percentile of Seagen's disclosed peer group.

How did shareholders vote on Seagen's executive compensation?

As disclosed, 54.38% of shareholders supported Seagen's executive compensation in the latest say-on-pay vote.

How much does Seagen spend in total on board compensation for fiscal 2022?

As disclosed, Seagen reported total board compensation of $2,143,971 for fiscal 2022.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table

Named executive officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension / NQDC	All other	Total
David Epstein	$190,385	$0	$14,815,386	$42,381,246	$0	$0	$73,529	$57,460,546
Chief Executive Officer
Roger Dansey	1,030,497	0	15,224,569	18,684,600	1,432,116	0	18,971	36,390,753
President, Research and Development and Chief Medical Officer
Clay Siegall	463,339	0	21,170,106	6,972,570	0	0	4,152,007	32,758,022
Former President and Chief Executive Officer
Jean Liu	678,750	0	4,723,235	0	532,350	0	18,971	5,953,306
Chief Legal Officer
Todd Simpson	672,425	0	4,446,543	0	569,354	0	18,971	5,707,293
Chief Financial Officer
Chip Romp	626,539	0	3,952,570	0	448,875	0	2,681	5,030,665
Executive Vice President, Commercial U.S.
Vaughn Himes	589,362	0	3,458,429	0	469,607	0	18,971	4,536,369
Chief Technical Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officer	FY2022 total	FY2021 total	FY2020 total	Δ FY2021→2022
David Epstein	$57,460,546	—	—	—
Roger Dansey	36,390,753	8,861,140	7,061,537	↑ +27,529,613
Clay Siegall	32,758,022	18,906,444	16,493,557	↑ +13,851,578
Jean Liu	5,953,306	5,123,207	3,913,724	↑ +830,099
Todd Simpson	5,707,293	5,986,940	4,601,531	↓ −279,647
Chip Romp	5,030,665	5,288,708	4,577,582	↓ −258,043
Vaughn Himes	4,536,369	4,911,876	3,678,473	↓ −375,507

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

Our compensation philosophy is to provide overall compensation that is competitive with biotechnology peers to attract and retain the highest caliber executive talent. Key objectives of our executive compensation program include: Supporting our business strategy; Aligning pay with company performance and executive officer performance with shareholder interests; Attracting, retaining and motivating our executive officers and maintaining competitiveness with companies we compete with for talent; Rewarding success in building both short- and long-term growth; Weighting pay deliberately toward "at risk" performance-based compensation; Ensuring that our pay practices are executed consistently and fairly for all executives, regardless of ethnicity or gender; Motivating performance that aligns with our corporate values of integrity, scientific excellence, teamwork, innovation and mutual respect.

CEO STI target (% of salary)	150%
CEO LTI target (% of salary)	—
Independent consultant	Aon
Clawback policy	True
Anti-hedging	True
Anti-pledging	True

Equity grants and outstanding awards

Grants of plan-based awards — fiscal year 2022

Executive	Award	Grant date	Threshold	Target	Granted	Maximum	Grant-date fair value
Clay Siegall	RSU	2022-05-15	—	—	13,991	—	$1,897,599
Clay Siegall	RSU	2022-05-15	—	—	15,411	—	2,090,194
Roger Dansey	PSU	2022-01-18	1,660	18,259	—	18,259	2,378,965
Vaughn Himes	PSU	2022-08-15	401	1,602	—	3,204	353,770
Clay Siegall	PSU	2022-05-15	2,001	8,006	—	16,012	1,887,317
Clay Siegall	PSU	2022-05-15	16,011	32,023	—	64,046	8,686,424
Todd Simpson	PSU	2022-08-15	515	2,060	—	4,120	454,910
Roger Dansey	OPTION	2022-11-09	55,000	275,000	—	275,000	18,684,600
Clay Siegall	RSU	2022-05-15	—	—	23,995	—	3,254,442
Jean Liu	RSU	2022-01-18	—	—	5,915	—	770,665
Jean Liu	RSU	2022-08-15	—	—	13,731	—	2,314,085
Chip Romp	PSU	2022-08-15	3,662	7,323	—	14,646	1,234,145
Clay Siegall	OPTION	2022-05-15	—	—	137,500	—	119,625
Clay Siegall	OPTION	2022-05-15	—	—	150,000	—	142,500
Clay Siegall	OPTION	2022-05-15	—	—	168,000	—	171,360
Clay Siegall	OPTION	2022-05-15	—	—	114,095	—	2,748,950
Todd Simpson	RSU	2022-08-15	—	—	15,447	—	2,603,283
Clay Siegall	RSU	2022-05-15	—	—	24,016	—	3,257,290
Jean Liu	PSU	2022-08-15	3,662	7,323	—	14,646	1,234,145
Todd Simpson	PSU	2022-08-15	4,119	8,238	—	16,476	1,388,350
Vaughn Himes	PSU	2022-08-15	3,204	6,408	—	12,816	1,079,940
Roger Dansey	PSU	2022-08-15	11,900	23,800	—	47,600	4,011,014
Jean Liu	PSU	2022-08-15	458	1,831	—	3,662	404,340
Clay Siegall	RSU	2022-05-15	—	—	714	—	96,840
Roger Dansey	PSU	2022-08-15	1,488	5,950	—	11,900	1,313,939
David Epstein	RSU	2022-11-09	—	—	107,389	—	14,815,386
Vaughn Himes	RSU	2022-08-15	—	—	12,014	—	2,024,719
Chip Romp	PSU	2022-08-15	458	1,831	—	3,662	404,340
Chip Romp	RSU	2022-08-15	—	—	13,731	—	2,314,085
Roger Dansey	RSU	2022-08-15	—	—	44,625	—	7,520,651
Clay Siegall	OPTION	2022-05-15	—	—	180,000	—	176,400
Clay Siegall	OPTION	2022-05-15	—	—	54,928	—	797,326
Clay Siegall	OPTION	2022-05-15	—	—	37,280	—	26,842
David Epstein	OPTION	2022-11-09	80,000	400,000	—	400,000	27,177,600
David Epstein	OPTION	2022-11-09	—	—	243,347	—	15,203,646
Clay Siegall	OPTION	2022-05-15	—	—	160,000	—	132,800
Clay Siegall	OPTION	2022-05-15	—	—	227,984	—	1,855,240
Clay Siegall	OPTION	2022-05-15	—	—	40,728	—	801,527

Vehicle mix — grant-date fair value by award type

Named executive officer	Time-vested (RSU)	Performance-vested (PSU)	Options / SARs	% performance-vested
Clay Siegall	$10,596,365	$10,573,741	$6,972,570	37.6%
Roger Dansey	7,520,651	7,703,918	18,684,600	22.7%
Vaughn Himes	2,024,719	1,433,710	0	41.5%
Todd Simpson	2,603,283	1,843,260	0	41.5%
Jean Liu	3,084,750	1,638,485	0	34.7%
Chip Romp	2,314,085	1,638,485	0	41.5%
David Epstein	14,815,386	0	42,381,246	0.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

Outstanding equity awards at fiscal year-end 2022

Executive	Award	Shares unvested	Exercise price	Market value unvested
Chip Romp	RSU	112	—	$14,393
Roger Dansey	RSU	129	—	16,578
Jean Liu	RSU	160	—	20,562
Todd Simpson	RSU	201	—	25,831
Vaughn Himes	RSU	201	—	25,831
Vaughn Himes	PSU	660	—	84,817
Clay Siegall	RSU	714	—	91,756
Jean Liu	PSU	720	—	92,527
Chip Romp	PSU	780	—	100,238
Todd Simpson	PSU	863	—	110,904
Roger Dansey	PSU	1,319	—	169,505
Jean Liu	PSU	1,354	—	174,003
Chip Romp	RSU	1,392	—	178,886
Chip Romp	PSU	1,392	—	178,886
Vaughn Himes	PSU	1,400	—	179,914
Chip Romp	PSU	1,420	—	182,484
Roger Dansey	RSU	1,442	—	185,311
Vaughn Himes	PSU	1,602	—	205,873
Todd Simpson	PSU	1,638	—	210,499
Chip Romp	RSU	1,722	—	221,294
Jean Liu	PSU	1,740	—	223,607
Chip Romp	RSU	1,798	—	231,061
Jean Liu	PSU	1,831	—	235,302
Chip Romp	PSU	1,831	—	235,302
Todd Simpson	PSU	2,060	—	264,731
Chip Romp	Option	2,204	72.64	—
Roger Dansey	PSU	2,378	—	305,597
Roger Dansey	PSU	2,436	—	313,050
Todd Simpson	PSU	2,436	—	313,050
Vaughn Himes	PSU	2,436	—	313,050
Vaughn Himes	PSU	2,638	—	339,009
Chip Romp	RSU	2,854	—	366,768
Jean Liu	PSU	2,878	—	369,852
Chip Romp	PSU	3,118	—	400,694
Vaughn Himes	RSU	3,298	—	423,826
Todd Simpson	PSU	3,454	—	443,874
Jean Liu	RSU	3,597	—	462,250
Chip Romp	RSU	3,897	—	500,803
Todd Simpson	RSU	4,317	—	554,778
Vaughn Himes	RSU	4,503	—	578,681
Jean Liu	RSU	4,748	—	610,165
Roger Dansey	PSU	5,277	—	678,147
Todd Simpson	RSU	5,322	—	683,930
Jean Liu	PSU	5,416	—	696,010
Clay Siegall	PSU	5,596	—	719,142
Vaughn Himes	PSU	5,601	—	719,785
Chip Romp	PSU	5,680	—	729,937
Jean Liu	RSU	5,915	—	760,137
Roger Dansey	PSU	5,950	—	764,635
Vaughn Himes	PSU	6,408	—	823,492
Vaughn Himes	RSU	6,538	—	840,198
Todd Simpson	PSU	6,552	—	841,998
Roger Dansey	RSU	6,596	—	847,652
Vaughn Himes	Option	6,815	161.82	—
Jean Liu	RSU	6,934	—	891,088
Vaughn Himes	Option	7,131	72.64	—
Jean Liu	PSU	7,323	—	941,079
Chip Romp	PSU	7,323	—	941,079
Roger Dansey	RSU	7,368	—	946,862
Chip Romp	RSU	7,430	—	954,829
Jean Liu	Option	7,434	161.82	—
Clay Siegall	PSU	7,485	—	961,897
Jean Liu	Option	7,520	72.64	—
Chip Romp	Option	8,054	161.82	—
Todd Simpson	PSU	8,238	—	1,058,665
Todd Simpson	RSU	8,321	—	1,069,332
Todd Simpson	Option	8,428	72.64	—
Clay Siegall	PSU	8,440	—	1,084,624
Todd Simpson	Option	8,921	161.82	—
Roger Dansey	PSU	9,510	—	1,222,130
Clay Siegall	PSU	9,607	—	1,234,596
Roger Dansey	Option	11,669	72.64	—
Vaughn Himes	RSU	12,014	—	1,543,919
Roger Dansey	RSU	12,879	—	1,655,080
Roger Dansey	Option	13,629	161.82	—
Jean Liu	RSU	13,731	—	1,764,571
Chip Romp	RSU	13,731	—	1,764,571
Vaughn Himes	Option	14,179	155.87	—
Jean Liu	Option	15,038	155.87	—
Todd Simpson	RSU	15,447	—	1,985,094

Director compensation

Director	Cash fees	Stock awards	Option awards	Non-equity incentive	All other	Total
Felix J. Baker, Ph.DIndependent · Board Chair · Compensation (Chair) · Governance	$130,000	$203,852	$194,675	—	$0	$528,527
David W. GryskaIndependent · Audit (Chair)	85,000	203,852	194,675	—	0	483,527
Nancy A. Simonian, M.DIndependent · Governance (Chair)	76,000	203,852	194,675	—	0	474,527
Ted W. Love, M.DIndependent · Audit	72,500	203,852	194,675	—	0	471,027
Alpna H. Seth, Ph.DIndependent · Audit	72,500	203,852	194,675	—	0	471,027
Daniel G. WelchIndependent · Compensation	70,000	203,852	194,675	—	0	468,527
John A. OrwinIndependent · Compensation	70,000	203,852	194,675	—	0	468,527
Sandra M. Swain, M.DIndependent · Governance · Newly elected	8,641	107,333	98,757	—	0	214,731
Marc E. Lippman, M.DIndependent · Governance · Not standing for re-election · Departed during FY	25,033	—	—	—	0	25,033
David R. EpsteinEmployee director · Newly elected	0	0	0	—	0	0

Board fee structure and ownership guideline

Annual cash retainer	$60,000
Annual equity retainer	$400,000
Per board meeting fee	—
Committee chair fees (audit / comp / nom-gov)	25,000 / 22,000 / 16,000
Stock ownership guideline	5x annual cash retainer for Board service (not including committee retainers)

Total cost of the board

Component	FY2022
Cash retainers and fees	$609,674
Equity awards (grant-date value)	$1,534,297
All other compensation	$0
Total cost of the board	$2,143,971

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names Seagen as a peer

Companies that benchmark against SGEN

1 company names SGEN as a compensation peer

EXACT SCIENCES CORPEXASFY2024

Each company listed discloses SGEN in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named SGEN in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

Disclosed peer group — fiscal year 2022

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

EXAS Exact Sciences CorporationUTHR United Therapeutics CorporationALNY Alnylam Pharmaceuticals, Inc. BeiGene, Ltd.BIIB Biogen Inc.BMRN BioMarin Pharmaceutical Inc.EXEL Exelixis, Inc.HZNP Horizon Therapeutics plcINCY Incyte CorporationJAZZ Jazz Pharmaceuticals plcMRNA Moderna, Inc.NBIX Neurocrine Biosciences, Inc.REGN Regeneron Pharmaceuticals, Inc.VRTX Vertex Pharmaceuticals Incorporated

Peer reciprocity

The companies Seagen names as compensation peers that name it back in their own disclosed peer groups.

Exact Sciences Corporation (EXAS)²⁷⁶Horizon Therapeutics plc (HZNP)²⁷⁷

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

Rank	Company	FY	Chief executive	Salary	Stock awards	Option awards	Non-equity incentive	Total
1	Seagen	2022	David Epstein	$190,385	$14,815,386	$42,381,246	$0	$57,460,546
2	Exelixis, Inc.	2025	Michael Morrissey	1,306,040	30,539,552	0	1,382,591	33,239,183
3	Incyte Corporation	2025	William Meury	647,260	27,509,657	2,573,998	1,300,000	32,085,952
4	Biogen Inc.	2025	Christopher Viehbacher	1,727,885	18,368,875	0	3,190,875	23,646,004
5	BioMarin Pharmaceutical Inc.	2025	Alexander Hardy	1,130,769	16,833,629	1,909,310	1,644,500	21,927,563
6	Vertex Pharmaceuticals Incorporated	2025	Reshma Kewalramani	1,600,000	15,002,270	0	4,118,640	21,144,261
7	Horizon Therapeutics plc	2022	Timothy Walbert	1,292,727	16,601,305	0	0	20,103,869
8	Moderna, Inc.	2025	Stéphane Bancel	1,677,739	6,897,455	6,897,425	4,302,360	19,932,217
9	Jazz Pharmaceuticals plc	2025	Renee Gala	1,003,269	16,138,433	0	1,980,000	19,151,558
10	United Therapeutics Corporation	2025	Martine Rothblatt	1,545,005	6,067,990	6,075,804	4,281,875	18,038,972
11	Exact Sciences Corporation	2024	Kevin Conroy	1,083,368	13,496,138	0	712,329	15,539,378
12	Alnylam Pharmaceuticals, Inc.	2025	Yvonne Greenstreet	1,404,200	5,512,500	4,363,380	3,562,500	14,867,600
13	Neurocrine Biosciences, Inc.	2025	Kyle Gano	920,000	5,750,023	5,750,006	0	13,448,935
14	Regeneron Pharmaceuticals, Inc.	2025	Leonard Schleifer	1,979,922	—	—	3,682,655	7,280,549

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Incentive design against the same peers

Company	Annual incentive payout	Long-term vehicle mix	PSU measures include TSR	Compensation consultant
Seagen	130%	RSU 60 · PSU 40	Yes — Relative TSR	Aon
Alnylam Pharmaceuticals, Inc.	200%	PSU 50 · RSU 25 · Option 25	No	Pay Governance
Biogen Inc.	127%	PSU 60 · RSU 40	Yes	Pay Governance
BioMarin Pharmaceutical Inc.	130%	PSU 66 · RSU 21 · Options 13	Yes — Relative TSR	Aon Human Capital Solutions
Exact Sciences Corporation	47%	PSU 60 · RSU 40	No	Aon
Exelixis, Inc.	105%	PSU 50 · RSU 50	Yes — 2025 Relative TSR Goal	Aon
Horizon Therapeutics plc	100%	RSU 50 · PSU 50	Yes — Relative TSR	Aon
Incyte Corporation	138.6%	Performance Shares 60 · RSU 40	Yes — relative total shareholder return (TSR)	Aon
Jazz Pharmaceuticals plc	150%	PSU 50 · RSU 50	Yes — Relative TSR	Aon
Moderna, Inc.	170%	PSU 50 · Options 50	No	Pay Governance LLC
Neurocrine Biosciences, Inc.	105%	Option 50 · PRSU 30 · RSU 20	No	Frederic W. Cook & Co., Inc.
Regeneron Pharmaceuticals, Inc.	155%	Options 60 · RSU 40	not disclosed	Pay Governance LLC
United Therapeutics Corporation	221%	PSO 50 · PSU 50	No	Aon
Vertex Pharmaceuticals Incorporated	not disclosed	PSU 55 · RSU 45	No	Pearl Meyer

Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.

Say-on-pay history and pay ratio

Meeting year	Meeting date	For	Against	Abstain	Support	Outcome
2023	2023-05-31	90,103,443	75,602,290	151,486	54.38%	Passed
2022	2022-05-19	140,889,623	24,997,815	72,795	84.93%	Passed
2021	2021-05-19	138,283,308	23,289,861	85,005	85.59%	Passed
2020	2020-05-19	149,358,302	7,864,729	193,802	95%	Passed
2019	2019-05-23	106,830,456	39,391,697	132,215	73.06%	Passed
2018	2018-05-18	138,922,693	1,894,754	105,448	98.65%	Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting year	Meeting date	Approval — company’s computation
2023	2023-05-31	54.38%^a
2022	2022-05-19	84.93%^b
2021	2021-05-19	85.59%^c

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

c. Voting standard not stated in the filing.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

Insider trades since the proxy

Every insider equity transaction reported on Form 4 after the 2022 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

Insider	Role	Transaction date	Code	Shares	Price	Value	Security	Source
Vaughn Himes	Chief Technical Officer	2023-12-14	D	8,333	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	20,626	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	642	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	15,719	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	636	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	41,453	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	1,333	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	41,343	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	1,301	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	47,844	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	40,293	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	34,946	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	17,662	—	—	Derivative, Class A Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	119,471	229	27,358,859	Common	Form 4 ↗
Vaughn Himes	Chief Technical Officer	2023-12-14	D	14,874	229	3,406,146	Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	5,149	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	8,582	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	3,432	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	1,827	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	13,279	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	4,980	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	2,575	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	4,291	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	41,174	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	16,547	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	10,184	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	1,717	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	11,900	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	4,756	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	25,747	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	2,260	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	33,468	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	8,586	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	3,298	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	154,000	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	41,250	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	642	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	32,073	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	636	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	18,083	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	1,333	—	—	Derivative, Class A Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	6,140	—	—	Derivative, Class A Common	Form 4 ↗
David W. Gryska	Director	2023-12-14	D	2,044	—	—	Derivative, Class A Common	Form 4 ↗
David W. Gryska	Director	2023-12-14	D	3,676	—	—	Derivative, Class A Common	Form 4 ↗
David W. Gryska	Director	2023-12-14	D	3,462	—	—	Derivative, Class A Common	Form 4 ↗
David W. Gryska	Director	2023-12-14	D	3,171	—	—	Derivative, Class A Common	Form 4 ↗
David W. Gryska	Director	2023-12-14	D	7,038	—	—	Derivative, Class A Common	Form 4 ↗
David W. Gryska	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
David R. Epstein	Director	2023-12-14	D	13,217	—	—	Derivative, Class A Common	Form 4 ↗
David R. Epstein	Director	2023-12-14	D	5,286	—	—	Derivative, Class A Common	Form 4 ↗
David R. Epstein	Director	2023-12-14	D	3,965	—	—	Derivative, Class A Common	Form 4 ↗
David R. Epstein	Director	2023-12-14	D	6,608	—	—	Derivative, Class A Common	Form 4 ↗
David R. Epstein	Director	2023-12-14	D	2,644	—	—	Derivative, Class A Common	Form 4 ↗
David R. Epstein	Director	2023-12-14	D	39,650	—	—	Derivative, Class A Common	Form 4 ↗
David W. Gryska	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
David R. Epstein	Director	2023-12-14	D	80,541	—	—	Derivative, Class A Common	Form 4 ↗
David R. Epstein	Director	2023-12-14	D	224,000	—	—	Derivative, Class A Common	Form 4 ↗
David W. Gryska	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
David R. Epstein	Director	2023-12-14	D	240,451	—	—	Derivative, Class A Common	Form 4 ↗
David R. Epstein	Director	2023-12-14	D	2,896	—	—	Derivative, Class A Common	Form 4 ↗
David W. Gryska	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	4,622	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	1,798	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	21,915	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	642	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	17,205	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	636	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	43,786	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	1,333	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	40,523	—	—	Derivative, Class A Common	Form 4 ↗
David R. Epstein	Director	2023-12-14	D	16,407	229	3,757,203	Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	40,344	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	35,293	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	7,446	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	48,748	229	11,163,292	Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	1,747	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	2,912	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	1,165	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	1,305	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	874	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	1,457	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	12,688	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	9,423	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	5,554	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	583	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	3,662	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	2,708	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	13,107	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	1,389	—	—	Derivative, Class A Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	10,298	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	1,966	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	3,276	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	1,310	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	1,827	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	983	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	1,639	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	14,251	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	11,400	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	6,666	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	656	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	4,120	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	3,276	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	14,746	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	5,547	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	2,158	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	10,526	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	26,427	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	642	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	20,774	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	636	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	49,232	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	1,333	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	47,904	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	1,301	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	93,292	229	21,363,868	Common	Form 4 ↗
Roger Dansey	President, R&D & CMO	2023-12-14	D	38,338	229	8,779,402	Common	Form 4 ↗
Jean Liu	Chief Legal Officer	2023-12-14	D	4,436	—	—	Derivative, Class A Common	Form 4 ↗
John A. Orwin	Director	2023-12-14	D	12,500	—	—	Derivative, Class A Common	Form 4 ↗
John A. Orwin	Director	2023-12-14	D	29,003	229	6,641,687	Common	Form 4 ↗
David W. Gryska	Director	2023-12-14	D	8,750	—	—	Derivative, Class A Common	Form 4 ↗
David W. Gryska	Director	2023-12-14	D	49,003	229	11,221,687	Common	Form 4 ↗
Daniel G. Welch	Director	2023-12-14	D	4,750	229	1,087,750	Common	Form 4 ↗
Sandra M. Swain	Director	2023-12-14	D	2,044	—	—	Derivative, Class A Common	Form 4 ↗
Sandra M. Swain	Director	2023-12-14	D	1,763	—	—	Derivative, Class A Common	Form 4 ↗
Sandra M. Swain	Director	2023-12-14	D	778	229	178,162	Common	Form 4 ↗
Ted W. Love	Director	2023-12-14	D	2,044	—	—	Derivative, Class A Common	Form 4 ↗
Ted W. Love	Director	2023-12-14	D	449	—	—	Derivative, Class A Common	Form 4 ↗
Ted W. Love	Director	2023-12-14	D	3,676	—	—	Derivative, Class A Common	Form 4 ↗
Ted W. Love	Director	2023-12-14	D	3,462	—	—	Derivative, Class A Common	Form 4 ↗
Ted W. Love	Director	2023-12-14	D	4,460	—	—	Derivative, Class A Common	Form 4 ↗
Ted W. Love	Director	2023-12-14	D	4,255	229	974,395	Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	1,395	—	—	Derivative, Class A Common	Form 4 ↗
Todd Simpson	Chief Financial Officer	2023-12-14	D	11,585	—	—	Derivative, Class A Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	3,676	—	—	Derivative, Class A Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	3,462	—	—	Derivative, Class A Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	3,371	—	—	Derivative, Class A Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	7,038	—	—	Derivative, Class A Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	8,750	—	—	Derivative, Class A Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	42,977,301	229	9,841,801,929	Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	1,731,202	229	396,445,258	Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	23,277	229	5,330,433	Common	Form 4 ↗
BAKER BROS. ADVISORS LP	Director	2023-12-14	D	23,280	229	5,331,120	Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	2,912	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	1,165	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	1,044	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	874	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	1,457	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	12,688	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	9,883	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	6,017	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	583	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	3,662	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	2,840	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	13,107	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	1,294	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	10,298	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	4,953	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	1,948	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	861	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	2,854	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	3,179	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	642	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	23,526	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	617	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	18,711	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	11,849	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	1,376	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	12,476	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	1,301	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	19,719	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	2,156	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	17,374	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	33,796	229	7,739,284	Common	Form 4 ↗
John A. Orwin	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
David R. Epstein	Director	2023-12-14	D	7,930	—	—	Derivative, Class A Common	Form 4 ↗
Chip Romp	EVP, Commercial U.S.	2023-12-14	D	1,747	—	—	Derivative, Class A Common	Form 4 ↗
Alpna Seth	Director	2023-12-14	D	2,044	—	—	Derivative, Class A Common	Form 4 ↗
Alpna Seth	Director	2023-12-14	D	3,676	—	—	Derivative, Class A Common	Form 4 ↗
Alpna Seth	Director	2023-12-14	D	3,462	—	—	Derivative, Class A Common	Form 4 ↗
Alpna Seth	Director	2023-12-14	D	3,171	—	—	Derivative, Class A Common	Form 4 ↗
Alpna Seth	Director	2023-12-14	D	7,038	—	—	Derivative, Class A Common	Form 4 ↗
Alpna Seth	Director	2023-12-14	D	14,250	—	—	Derivative, Class A Common	Form 4 ↗
Alpna Seth	Director	2023-12-14	D	12,953	229	2,966,237	Common	Form 4 ↗
Nancy A. Simonian	Director	2023-12-14	D	2,044	—	—	Derivative, Class A Common	Form 4 ↗
Nancy A. Simonian	Director	2023-12-14	D	3,676	—	—	Derivative, Class A Common	Form 4 ↗
Nancy A. Simonian	Director	2023-12-14	D	3,462	—	—	Derivative, Class A Common	Form 4 ↗
Nancy A. Simonian	Director	2023-12-14	D	3,171	—	—	Derivative, Class A Common	Form 4 ↗
Nancy A. Simonian	Director	2023-12-14	D	7,038	—	—	Derivative, Class A Common	Form 4 ↗
Nancy A. Simonian	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
Nancy A. Simonian	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
Nancy A. Simonian	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
Nancy A. Simonian	Director	2023-12-14	D	9,260	—	—	Derivative, Class A Common	Form 4 ↗
Nancy A. Simonian	Director	2023-12-14	D	8,750	—	—	Derivative, Class A Common	Form 4 ↗
Nancy A. Simonian	Director	2023-12-14	D	62,753	229	14,370,437	Common	Form 4 ↗
Daniel G. Welch	Director	2023-12-14	D	2,044	—	—	Derivative, Class A Common	Form 4 ↗
Daniel G. Welch	Director	2023-12-14	D	10,725	229	2,456,025	Common	Form 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

Sources (277 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

Section 01, David Epstein. DEF 14A, filed 2023-04-18. Section “Summary Compensation Table” · page 87. As printed: 57,460,546. View filing ↗
Section 01, Roger Dansey. DEF 14A, filed 2023-04-18. Section “Summary Compensation Table” · page 87. As printed: 36,390,753. View filing ↗
Section 01, Clay Siegall. DEF 14A, filed 2023-04-18. Section “Summary Compensation Table” · page 87. As printed: 32,758,022. View filing ↗
Section 01, Jean Liu. DEF 14A, filed 2023-04-18. Section “Summary Compensation Table” · page 87. As printed: 5,953,306. View filing ↗
Section 01, Todd Simpson. DEF 14A, filed 2023-04-18. Section “Summary Compensation Table” · page 87. As printed: 5,707,293. View filing ↗
Section 01, Chip Romp. DEF 14A, filed 2023-04-18. Section “Summary Compensation Table” · page 87. As printed: 5,030,665. View filing ↗
Section 01, Vaughn Himes. DEF 14A, filed 2023-04-18. Section “Summary Compensation Table” · page 87. As printed: 4,536,369. View filing ↗
Section 03, Clay Siegall RSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall RSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Roger Dansey PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Vaughn Himes PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Todd Simpson PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Roger Dansey OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall RSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Jean Liu RSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Jean Liu RSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Chip Romp PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Todd Simpson RSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall RSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Jean Liu PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Todd Simpson PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Vaughn Himes PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Roger Dansey PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Jean Liu PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall RSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Roger Dansey PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, David Epstein RSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Vaughn Himes RSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Chip Romp PSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Chip Romp RSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Roger Dansey RSU. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, David Epstein OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, David Epstein OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 03, Clay Siegall OPTION. DEF 14A, filed 2023-04-18. Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. View filing ↗
Section 08, Felix J. Baker, Ph.D. DEF 14A, filed 2023-04-18. Section “Director Compensation”. As printed: 528,527. View filing ↗
Section 08, David W. Gryska. DEF 14A, filed 2023-04-18. Section “Director Compensation”. As printed: 483,527. View filing ↗
Section 08, Nancy A. Simonian, M.D. DEF 14A, filed 2023-04-18. Section “Director Compensation”. As printed: 474,527. View filing ↗
Section 08, Ted W. Love, M.D. DEF 14A, filed 2023-04-18. Section “Director Compensation”. As printed: 471,027. View filing ↗
Section 08, Alpna H. Seth, Ph.D. DEF 14A, filed 2023-04-18. Section “Director Compensation”. As printed: 471,027. View filing ↗
Section 08, Daniel G. Welch. DEF 14A, filed 2023-04-18. Section “Director Compensation”. As printed: 468,527. View filing ↗
Section 08, John A. Orwin. DEF 14A, filed 2023-04-18. Section “Director Compensation”. As printed: 468,527. View filing ↗
Section 08, Sandra M. Swain, M.D. DEF 14A, filed 2023-04-18. Section “Director Compensation”. As printed: 214,731. View filing ↗
Section 08, Marc E. Lippman, M.D. DEF 14A, filed 2023-04-18. Section “Director Compensation”. As printed: 25,033. View filing ↗
Section 08, David R. Epstein. DEF 14A, filed 2023-04-18. Section “Director Compensation”. As printed: 0. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Vaughn Himes 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David W. Gryska 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David W. Gryska 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David W. Gryska 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David W. Gryska 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David W. Gryska 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David W. Gryska 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David R. Epstein 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David R. Epstein 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David R. Epstein 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David R. Epstein 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David R. Epstein 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David R. Epstein 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David W. Gryska 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David R. Epstein 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David R. Epstein 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David W. Gryska 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David R. Epstein 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David R. Epstein 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David W. Gryska 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David R. Epstein 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Roger Dansey 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Jean Liu 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, John A. Orwin 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, John A. Orwin 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David W. Gryska 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David W. Gryska 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Daniel G. Welch 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Sandra M. Swain 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Sandra M. Swain 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Sandra M. Swain 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Ted W. Love 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Ted W. Love 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Ted W. Love 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Ted W. Love 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Ted W. Love 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Ted W. Love 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Todd Simpson 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, BAKER BROS. ADVISORS LP 2023-12-14. Form 4, filed 2023-12-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, John A. Orwin 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, David R. Epstein 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Chip Romp 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Alpna Seth 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Alpna Seth 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Alpna Seth 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Alpna Seth 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Alpna Seth 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Alpna Seth 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Alpna Seth 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Nancy A. Simonian 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Nancy A. Simonian 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Nancy A. Simonian 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Nancy A. Simonian 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Nancy A. Simonian 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Nancy A. Simonian 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Nancy A. Simonian 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Nancy A. Simonian 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Nancy A. Simonian 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Nancy A. Simonian 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Nancy A. Simonian 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Daniel G. Welch 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Daniel G. Welch 2023-12-14. Form 4, filed 2023-12-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 06, 2023 vote. Form 8-K, filed 2023-06-01. Item 5.07 · say-on-pay result. As reported: 54.38% (votes for as printed: 90,103,443). View filing ↗
Section 06, 2022 vote. Form 8-K, filed 2022-05-19. Item 5.07 · say-on-pay result. As reported: 84.93% (votes for as printed: 140,889,623). View filing ↗
Section 06, 2021 vote. Form 8-K, filed 2021-05-19. Item 5.07 · say-on-pay result. As reported: 85.59%. View filing ↗
Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
Section 09b board cost (computed). Computed. Cash 609,674 + equity 1,534,297 + all other 0 = 2,143,971, summed across the director compensation table rows.
Seagen (subject), Section 10b CEO total. DEF 14A, filed 2023-04-18. CEO total compensation as printed in Seagen's own proxy. As printed: 57,460,546. View filing ↗
Exelixis, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-15. CEO total compensation as printed in Exelixis, Inc.'s own proxy. As printed: 33,239,183. View filing ↗
Incyte Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Incyte Corporation's own proxy. As printed: 32,085,952. View filing ↗
Biogen Inc., Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Biogen Inc.'s own proxy. As printed: 23,646,004. View filing ↗
BioMarin Pharmaceutical Inc., Section 10b CEO total. DEF 14A, filed 2026-04-21. CEO total compensation as printed in BioMarin Pharmaceutical Inc.'s own proxy. As printed: 21,927,563. View filing ↗
Vertex Pharmaceuticals Incorporated, Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Vertex Pharmaceuticals Incorporated's own proxy. As printed: 21,144,261. View filing ↗
Horizon Therapeutics plc, Section 10b CEO total. DEF 14A, filed 2023-06-30. CEO total compensation as printed in Horizon Therapeutics plc's own proxy. As printed: 20,103,869. View filing ↗
Moderna, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-16. CEO total compensation as printed in Moderna, Inc.'s own proxy. As printed: 19,932,217. View filing ↗
Jazz Pharmaceuticals plc, Section 10b CEO total. DEF 14A, filed 2026-06-08. CEO total compensation as printed in Jazz Pharmaceuticals plc's own proxy. As printed: 19,151,558. View filing ↗
United Therapeutics Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in United Therapeutics Corporation's own proxy. As printed: 18,038,972. View filing ↗
Exact Sciences Corporation, Section 10b CEO total. DEF 14A, filed 2025-04-29. CEO total compensation as printed in Exact Sciences Corporation's own proxy. As printed: 15,539,378. View filing ↗
Alnylam Pharmaceuticals, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Alnylam Pharmaceuticals, Inc.'s own proxy. As printed: 14,867,600. View filing ↗
Neurocrine Biosciences, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-15. CEO total compensation as printed in Neurocrine Biosciences, Inc.'s own proxy. As printed: 13,448,935. View filing ↗
Regeneron Pharmaceuticals, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Regeneron Pharmaceuticals, Inc.'s own proxy. As printed: 7,280,549. View filing ↗
Section 10a, Exact Sciences Corporation reciprocity. DEF 14A. Exact Sciences Corporation names Seagen in its own disclosed peer group (read from its most recent proxy). View filing ↗
Section 10a, Horizon Therapeutics plc reciprocity. DEF 14A. Horizon Therapeutics plc names Seagen in its own disclosed peer group (read from its most recent proxy). View filing ↗